TICKERNOMICS Sign up
Last Update: 2024-12-27 15:25:55
ChromaDex Corp. ( CDXC ) https://www.chromadex.com
5.61USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
CDXC
279.05%
SPY
32.66%
CDXC
45.71%
SPY
108.59%
CDXC
25.50%
SPY
302.52%
CDXC
117.44%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
436.28
406.96
0.42
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
293.79
4.76
12.69
1.40
0.00
150.34
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
6.26
63.49
2.82
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
12.1216
3.75
6.29
2.12
Other Earnings and Cash Flow Stats:
ChromaDex Corp. ( CDXC ) Net Income TTM ($MM) is 1.49
ChromaDex Corp. ( CDXC ) Operating Income TTM ($MM) is 0.85
ChromaDex Corp. ( CDXC ) Owners' Earnings Annual ($MM) is 7.28
ChromaDex Corp. ( CDXC ) Current Price to Owners' Earnings ratio is 15.25
ChromaDex Corp. ( CDXC ) EBITDA TTM ($MM) is 1.84
ChromaDex Corp. ( CDXC ) EBITDA Margin is 2.82%
Capital Allocation:
ChromaDex Corp. ( CDXC ) has paid 0.00 dividends per share and bought back -2.718 million shares in the past 12 months
ChromaDex Corp. ( CDXC ) has reduced its debt by 0.884 million USD in the last 12 months
Capital Structure:
ChromaDex Corp. ( CDXC ) Interest-bearing Debt ($MM) as of last quarter is 2
ChromaDex Corp. ( CDXC ) Annual Working Capital Investments ($MM) are -3
ChromaDex Corp. ( CDXC ) Book Value ($MM) as of last quarter is 34
ChromaDex Corp. ( CDXC ) Debt/Capital as of last quarter is 8%
Other Balance Sheet Stats:
ChromaDex Corp. ( CDXC ) has 32 million in cash on hand as of last quarter
ChromaDex Corp. ( CDXC ) has 17 million of liabilities due within 12 months, and long term debt 0 as of last quarter
ChromaDex Corp. ( CDXC ) has 77 common shares outstanding as of last quarter
ChromaDex Corp. ( CDXC ) has 0 million USD of preferred stock value
Academic Scores:
ChromaDex Corp. ( CDXC ) Altman Z-Score is 9.69 as of last quarter
ChromaDex Corp. ( CDXC ) Piotroski Score is 7.00 as of last quarter
Corporate Governance:
ChromaDex Corp. ( CDXC ) largest shareholder is owning shares at 0.00 ($MM) value
Jaksch Frank L Jr(an insider) Sold 37161 shares of ChromaDex Corp. ( CDXC ) for the amount of $229955.98 on 2024-12-13
35.39% of ChromaDex Corp. ( CDXC ) is held by insiders, and 22.57% is held by institutions
ChromaDex Corp. ( CDXC ) went public on 2008-07-15
Other ChromaDex Corp. ( CDXC ) financial metrics:
FCF:4.00
Unlevered Free Cash Flow:8.27
EPS:0.10
Operating Margin:6.26
Gross Profit Margin:63.49
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:21.86
Beta:2.12
Buffet's Owners Earnings:7.28
Price to Owner's Earnings:15.25
About ChromaDex Corp. ( CDXC ) :
ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.